HHA Headlines: The Haas Healthcare Association's Bi-Weekly Publication
Thursday, April 5, 2023
Looking Back at Haas Healthcare Conference 2023
Case Competitions & Accelerator Programs
-
Accenture HealthTech Innovation Challenge. They are looking for the best HealthTech startups across North America to compete in our challenge for the chance to connect, collaborate, learn and scale with our community of healthcare organizations and investors. Apply here. For more information, reach out to: Sonia.salunke@accenture.com
Healthcare News
-
Zócalo Health teams up with Mark Cuban's Cost Plus Drugs to expand access to affordable medications for its users. Read more here.
-
What’s Behind Losses At Large Nonprofit Health Systems? Read more here.
-
AWS announces healthcare workforce accelerator cohort. Read more here.
-
Instacart expands health division with provider-facing tools. Read more here.
-
Uber Health expands same-day prescription drug delivery. Read more here.
-
Former Aetna CEO to Take Helm of Health Insurer Oscar. Read more here.
Career Announcements & Opportunities
Full-Time Jobs
-
Arcus Biosciences is looking for Associate Director, Clinical Operations (Office OR Remote). Link
-
Kyverna Therapeutics is looking for Associate Director, Project Management, R&D. Link
-
Alvarez & Marsal is looking for Healthcare Consultant. Link
-
Roche is looking for Regional Business Manager, Sequencing and Life Sciences. Link
-
Simon Kucher is looking for a Sr. Manager, Healthcare Technology and Solutions Team. Link
-
Blue Shield of California is looking for a Strategy and Innovation Analyst. Link
-
Benchling is looking for a Project Manager. Link
Summer Internships
-
Miriam Pharmaceuticals 2023 Investor Relationship MBA Intern. Link
-
Stern Investor Relations 2023 Summer - Biotech Investor Relations. Link
-
Maze Therapeutics Summer Internship Program 2023 - Business Development. Link
-
Guardant Health Summer 2023 Internship - Managed Care. Link
Insights from the recent FDA Approval of Narcan for Over-the-Counter Sales
The Food and Drug Administration (FDA) has authorized the sale of Narcan, a prescription nasal spray that reverses opioid overdoses, over the counter. This move, long-sought by public health officials and treatment experts, aims to reduce the high rates of drug-related fatalities in the United States. By late summer, over-the-counter Narcan is expected to be available in big-box chains, supermarkets, convenience stores, gas stations, and online retailers. Some cities, such as New York City, are also planning to install Narcan vending machines. While public health officials welcome the FDA's authorization, concerns remain about the affordability of Narcan as it transitions to over-the-counter status. Furthermore, the FDA is encouraging other manufacturers of prescription naloxone to apply for over-the-counter approval to increase competition and potentially lower prices. ÔÇï ÔÇï ÔÇï ÔÇï ÔÇï
For the NYT’s article on this topic, read here.
For an interesting take on this issue, read here.
Your contributions are Welcome! Please submit your ideas and requests for the newsletter using this form.
We love to hear from you! Please submit your suggestions and feedback here.